Bristol-Myers Squibb Company Profit Margin

Bristol-Myers Squibb Company (BRM.DE) currently reports a profit margin of 18.87% as of June 2026. That compares with 10.58% in the prior-year period — up 78.3% year over year. That is above the Healthcare sector average of 9.71%. Use the charts on this page to explore Bristol-Myers Squibb Company's profit margin history and peer comparisons.

Bristol-Myers Squibb Company's profit margin increased from 10.58% to 18.87% — a 78.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb Company's profit margin of 18.87% is higher than the Healthcare sector average of 9.71%. That is roughly 94.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bristol-Myers Squibb Company's current 18.87% should be judged against Healthcare norms (sector average: 9.71%) and against BRM.DE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 18.87%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.71%. From there, open related valuation or income-statement pages for Bristol-Myers Squibb Company, and consider following BRM.DE for alerts when major investors trade the stock.